Rehabilitación multidisciplinaria y multiorgánica del paciente post COVID-19
Palabras clave:
Cardiopulmonar, dificultad respiratoria, funcional, dolor, rehabilitación, COVID-19.Resumen
La enfermedad por COVID-19 se declaró pandemia en el mes de marzo de 2020. Sus
manifestaciones clínicas son variadas: desde pacientes asintomáticos hasta enfermedad
respiratoria severa y falla multiorgánica, lo cual puede conducir a la muerte, aquellos
pacientes que se agravan requieren manejo invasivo en unidad de cuidados intensivos,
pasando a dos estadios de la evolución natural de la enfermedad, bien sea la supervivencia
o la no supervivencia, para aquellos que logran con el apoyo multidisciplinario salir
abantes, se generan largo plazo un número considerable de secuelas multisistémicas. ,
durante esta revisión sistemática de la literatura se expondrá los componentes clínicos a
nivel cardiopulmonar , musculoesquelético y Mental , así como el papel interdisciplinario
en el manejo rehabilitante del paciente post COVID – 19.
Cuando un paciente sale de la hospitalización por esta casuística, cree que esta
recuperado del todo, y es allí donde se convierte en un reto de acción medica conjunta
entre el Internista, el Anestesiólogo, el Fisiatra, El siquiatra, el Paliativista y el
Ortopedista, como especialidades tratantes directas durante su proceso de progresión
patológica, demostrar el rumbo en la rehabilitación integral que debería protocolizarse
en este tipo de pacientes, sin olvidarse aquellos pacientes con enfermedades terminales
de base que lograron sobrevivir a la infección descrita y por el contrario acrecentaron
sus secuelas y afecciones algicas derivadas de las mismas.
Citas
World health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020. Disponible en: https://www.who.int/docs/defaultsource/coronaviruse/who-china-joint-mission-on-covid-19- final-report.p
Liu W, Tao ZW, Lei W, Ming-Li Y, Kui L, Ling Z, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020. doi: 1097/CM9.0000000000000775
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China 2020. JAMA. doi: 10.1001/Jama2020.1585.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. 2020. Lancet. 2020;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7
Policy paper; Coronavirus action plan: a guide to what you can expect across the UK. Department of Health and Social Care Published 3 March 2020.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.
Li J, Li S, Cai Y, Liu Q, Li X, Zeng Z, et al. Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China. Med Rxiv. 2020.
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020. doi: 10.7326/M20-0504.
Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020.
Hung LS. The SARS epidemic in Hong Kong: what lessons have we learned? J R Soc Med. 2003;96(8):374-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539564/
To KK-W, Tsang OT-Y, Chik-Yan Yip C, Chan K-H, Wu T-C, Chan JMC, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020. pii: ciaa149. doi: 10.1093/cid/ciaa149
Van Doremalen, N, Bushmaker, T, Morris, DH, Holbrook, MG, Gamble, A, Williamson, BN, et al (2020). Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020. doi: 10.1056/NEJMc2004973. 16
Ministerio de Sanidad. Procedimientos de actuación para los servicios de prevención de riesgos laborales frente a la exposición al nuevo coronavirus (SARS-COV-2). 11 de marzo de 2020.
Simonds AK, Hanak A, Chatwin M, Morrell M, Hall A, Parker KH, et al. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess. 2010;14(46):131-172. doi: 10.3310/hta14460-02.
Association of Chartered Physiotherapists in Respiratory Care. COVID 19: Respiratory Physiotherapy On Call Information and Guidance. Version 1. 12 de Marzo de 2020. Accesible en: https://www.acprc.org.uk/resources/covid-19-information/
Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, et al. Physiotherapy management for COVID-19 in the acute hospital setting. Recommendations to guide clinical practice. Version 1.0, published 23 March 2020.
Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology. 2020.
Shi H, Han X, Jiang N, Cao Y, Osamah A, Gu J, et al. (2020) Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020. pii: S1473-3099(20)30086-4. doi: 10.1016/S1473-3099(20)30086-4.
Queensland Health, Clinical Excellence Division COVID-19 Action Plan: Statewide General Medicine Clinical Network, 2020.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020. doi: 10.1056/NEJMoa2002032.
Zhonghua J, He H, Hu X, Za Z. Chinese Association of Rehabilitation Medicine; Respiratory rehabilitation committee of Chinese Association of Rehabilitation Medicine; Cardiopulmonary rehabilitation Group of Chinese Society of Physical Medicine and Rehabilitation. Recommendations for respiratory rehabilitation of COVID-19 in adult. 2020;43(0):E029. doi: 10.3760/cma.j.cn112147-20200228-00206.
Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 2020;17(5). pii: E1729. doi: 10.3390/ijerph17051729.
Ministerio de Sanidad. Manejo clínico del COVID-19: unidades de cuidado intensivos. Publicado 19 Marzo 2020 .
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. pii: S0140-6736(20)30566-3. doi: 10.1016/S0140-6736(20)30566-3 17
Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care, 2020;10(1):33. doi: 10.1186/s13613-020-00650-2.
Moses R. COVID 19 and Respiratory Physiotherapy Referral Guidelines. Disponible en: https://www.acprc.org.uk/resources/covid-19-information/physiotherapy-guidance-forclinicians-and-managers/
Manejo clínico del COVID-19: unidades de cuidados intensivos. Hospital Italiano de Buenos Aires. 2020
Munshi L, Del Sorbo L, Adhikari NKJ, Hodgson CL, Wunsch H, Meade MO, et al. Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis. Ann Am Thorac Soc, 2017;14: S280–S288.
Gattinoni L, Carlesso E, Taccone P, Polli F, Guérin C, Mancebo J. et al. Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient metaanalysis. Minerva Anestesiol. 2010;76(6):448-54.
Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care. 2020;24(1):28. doi: 10.1186/s13054-020-2738-5.
Infografía publicada por el Servicio de Anestesiología y Reanimación del Hospital Universitari Clínic de Barcelona, 2020.
Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293-304.
Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med. 2014;371(3):287-8. doi: 10.1056/NEJMc1406274
Hickmann CE, Castanares-Zapatero D, Bialais E, Dugernier J, Tordeur A, Colmant L, et al. Teamwork enables high level of early mobilization in critically ill patients. Ann Intensive Care. 2016;6(1):80. doi: 10.1186/s13613-016-0184-y.
Schreiber A, Fusar Poli B, Bos LD, Nenna R. Noninvasive ventilation in hypercapnic respiratory failure: from rocking beds to fancy masks. Breathe (Sheff). 2018;14(3):235-237. doi: 10.1183/20734735.018918. PMID:30186523; PMCID:PMC6118891.
Vorona S, Sabatini U, Al-Maqbali S, Bertoni M, Dres M, Bissett B, et al. Inspiratory Muscle Rehabilitation in Critically Ill Adults. A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2018 Jun;15(6):735-744. doi: 10.1513/AnnalsATS.201712-961OC. PMID:29584447; PMCID:PMC6137679.
Moses R. COVID 19 and Respiratory Physiotherapy Referral Guidelines. Disponible en: https://www.acprc.org.uk/resources/covid-19-information/physiotherapy-guidance-forclinicians-and-managers/
Hodgson CL, Stiller K, Needham DM, Tipping CJ, Harrold M, Baldwin CE, et al. Expert consensus and recommendations on safety criteria for active mobilization of mechanically ventilated critically ill adults. Crit Care, 2014. 18(6):658-666. doi: 10.1186/s13054-014-0658-y
Lau HM, Ng GY, Jones AY, Lee EW, Siu EH, Hui DS. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother, 2005,51(4):213-219. doi:10.1016/s0004- 9514(05)70002-7.
Almekhlafi GA, Albarrak MM, Mandourah Y, Hassan S, Alwan A, Abudayah A, et al. Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients. Crit Care. 2016;20(1):123. doi: 10.1186/s13054-016-1303-8.
Saxena SK. Coronavirus Disease 2019 (Covid-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics. Singapore: Springer; 2020;213 Disponible en: http://doi.org/10.1007/978-981-15-4814-7 2.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77(6):683-690. Disponible en: http://doi.org/10.1001/jamaneurol.2020.1127
Johns Hopkins University & Medicine. Coronavirus Resource Center. Covid-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. 2020. Disponible en: https://coronavirus.jhu.edu/map.html
Saavedra-Trujillo CH. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARSCOV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24(3): Suplemento 1. Disponible en: http://doi.org/10.22354/in.v24i3.851
Simpson R, Robinson L. Rehabilitation after critical illness in people with Covid-19 infection. Am J Phys Med Rehabil. 2020;99(6):470–474. Disponible en: http://doi.org/10.1097/PHM.0000000000001443
Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan detroit. JAMA Netw Open. 2020;3(6):e2012270. Disponible en: http://dx.doi.org/10.1001/jamanetworkopen.2020.12270
Wei Y-Y, Wang R-R, Zhang D-W, Tu Y-H, Chen C-S, Ji S, et al. Risk factors for severe Covid-19: Evidence from 167 hospitalized patients in Anhui, China. J Infect. 2020;81(1):e89–e92. Disponible en: http://dx.doi.org/10.1016/j.jinf.2020.04.010
Aytür YK, Köseoğlu BF, Taşkiran ÖÖ, Gökkaya NKO, Deli ali oğlu SÜ, Tur BS, et al. Pulmonary rehabilitation principles after SARS-CoV-2 (Covid-19): A guideline for the management of acute and subacute course. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi. 2020;23(2):111–28. Disponible en: http://dx.doi.org/10.31609/jpmrs.2020-75492
Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. Covid-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. Disponible en: https://doi.org/10.1038/s41569-020-0360-5
Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin angiotensinaldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382(17):1653-1659. Disponible en: http://dx.doi.org/10.1056/NEJMsr2005760
Gurwitz D. Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics. Drug Dev Res. 2020;81(5):537-540. Disponible en: https://doi.org/10.1002/ddr.21656
Liu PP, Blet A, Smyth D, Li H. The science underlying Covid-19: implications for the cardiovascular system. Circulation. 2020;142:68–78. Disponible en:https://doi.org/10.1161/circulationaha.120.047549
Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. Disponible en: https://doi.org/10.1056/nejmoa2002032
Descargas
Publicado
Versiones
- 2025-11-10 (2)
- 2021-04-15 (1)
Cómo citar
Número
Sección
Licencia
Derechos de autor 2021 Scientific and Eduaction Medical Journal
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Atribución – No comercial – Compartir igual: Esta licencia permite a otros distribuir, remezclar, retocar, y crear a partir de tu obra de modo no comercial, siempre y cuando te den crédito y licencien sus nuevas creaciones bajo las mismas condiciones.
Attribution-NonCommercial-ShareAlike 4.0 International
